RCM (RCMT) 10-Q 9 Nov 18 2018 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 29, 2018	Nov. 09, 2018
Document Information [Line Items]
Entity Registrant Name	RCM TECHNOLOGIES INC
Entity Central Index Key	700,841
Trading Symbol	rcmt
Current Fiscal Year End Date	--12-29
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Common Stock, Shares Outstanding (in shares)		12,725,978
Document Type	10-Q
Document Period End Date	Sep. 29, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q3
Amendment Flag	false

Consolidated Balance Sheets (Cu

Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 29, 2018	Dec. 30, 2017
Current assets:
Cash and cash equivalents	$ 710	$ 2,851
Accounts receivable, net	46,663	46,080
Transit accounts receivable	4,365	3,002
Prepaid expenses and other current assets	3,947	3,706
Total current assets	55,685	55,639
Property and equipment, net	3,694	3,446
Other assets:
Deposits	224	215
Goodwill	11,685	11,685
Intangible assets, net	65	105
Deferred tax assets, net, domestic	2,075	2,189
Total other assets	14,049	14,194
Total assets	73,428	73,279
Current liabilities:
Accounts payable and accrued expenses	8,099	8,634
Transit accounts payable	4,461	4,661
Accrued payroll and related costs	8,658	7,780
Income taxes payable	916	372
Liability for contingent consideration from acquisitions	553	741
Total current liabilities	22,687	22,188
Liability for contingent consideration from acquisitions	1,180	1,350
Borrowings under line of credit	24,460	27,279
Total liabilities	48,751	51,248
Stockholders’ equity:
Preferred stock, $1.00 par value; 5,000,000 shares authorized; no shares issued or outstanding	0	0
Common stock, $0.05 par value; 40,000,000 shares authorized; 15,108,399 shares issued and 12,285,227 shares outstanding at September 29, 2018 and 15,017,522 shares issued and 12,194,350 shares outstanding at December 30, 2017	755	751
Additional paid-in capital	105,243	104,540
Accumulated other comprehensive loss	(2,572)	(2,395)
Accumulated deficit	(63,762)	(65,878)
Treasury stock (2,823,172 shares at September 29, 2018 and December 30, 2017) at cost	(14,987)	(14,987)
Stockholders’ equity	24,677	22,031
Total liabilities and stockholders’ equity	73,428	73,279
Foreign Tax Authority [Member]
Current liabilities:
Deferred tax liability	$ 424	$ 431

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Sep. 29, 2018	Dec. 30, 2017
Preferred stock par value (in dollars per share)	$ 1	$ 1
Preferred stock, authorized (in shares)	5,000,000	5,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.05	$ 0.05
Common stock, authorized (in shares)	40,000,000	40,000,000
Common stock, issued (in shares)	15,108,399	15,017,522
Common stock, outstanding (in shares)	12,285,227	12,194,350
Treasury stock, shares (in shares)	2,823,172	2,823,172

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Sep. 29, 2018	Sep. 30, 2017
Revenues	$ 42,559	$ 43,827	$ 145,081	$ 135,680
Cost of services	31,571	32,109	108,803	100,097
Gross profit	10,988	11,718	36,278	35,583
Operating costs and expenses
Selling, general and administrative	9,412	9,700	29,909	30,092
Depreciation and amortization	344	422	1,156	1,229
Severance, professional fees and other charges			1,371	0
Change in contingent consideration				781
Operating costs and expenses	9,756	10,122	32,436	32,102
Operating income	1,232	1,596	3,842	3,481
Other (expense) income
Interest expense and other, net	(305)	(137)	(971)	(409)
Gain (loss) on foreign currency transactions	10	(17)	(19)	38
Other (expense) income	(295)	(154)	(990)	(371)
Income before income taxes	937	1,442	2,852	3,110
Income tax expense	253	422	736	1,351
Net income	$ 684	$ 1,020	$ 2,116	$ 1,759
Basic and diluted net earnings per share (in dollars per share)	$ 0.06	$ 0.08	$ 0.17	$ 0.15

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 29, 2018	Sep. 30, 2017
Net income	$ 2,116	$ 1,759
Other comprehensive (loss) gain	(177)	369
Comprehensive income	$ 1,939	$ 2,128

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - 9 months ended Sep. 29, 2018 - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Total
Balance (in shares) at Dec. 30, 2017	15,017,522				2,823,172
Balance at Dec. 30, 2017	$ 751	$ 104,540	$ (2,395)	$ (65,878)	$ (14,987)	$ 22,031
Issuance of stock under employee stock purchase plan (in shares)	90,877
Issuance of stock under employee stock purchase plan	$ 4	381				385
Translation adjustment			(177)			(177)
Share-based compensation expense		322				322
Net income				2,116		2,116
Balance (in shares) at Sep. 29, 2018	15,108,399				2,823,172
Balance at Sep. 29, 2018	$ 755	$ 105,243	$ (2,572)	$ (63,762)	$ (14,987)	$ 24,677

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 29, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net income	$ 2,116	$ 1,759
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	1,156	1,229
Change in contingent consideration		781
Share-based compensation expense	322	591
Provision for losses on accounts receivable	945	131
Deferred income tax expense	104	294
Changes in assets and liabilities:
Accounts receivable	(1,664)	3,682
Prepaid expenses and other current assets	(593)	230
Net of transit accounts receivable and payable	(1,560)	(1,189)
Accounts payable and accrued expenses	(219)	(1,313)
Accrued payroll and related costs	905	(185)
Income taxes payable	552	946
Total adjustments	(52)	5,197
Net cash provided by operating activities	2,064	6,956
Cash flows from investing activities:
Property and equipment acquired	(1,414)	(747)
Decrease in deposits	(9)	4
Net cash used in investing activities	(1,423)	(743)
Cash flows from financing activities:
Borrowings under line of credit	64,987	60,411
Repayments under line of credit	(67,807)	(65,271)
Issuance of stock for employee stock purchase plan	385	394
Common stock repurchases		(365)
Contingent consideration paid	(300)	(790)
Net cash used in financing activities	(2,735)	(5,621)
Effect of exchange rate changes on cash and cash equivalents	(47)	(46)
(Decrease) increase in cash and cash equivalents	(2,141)	546
Cash and cash equivalents at beginning of period	2,851	279
Cash and cash equivalents at end of period	710	825
Supplemental cash flow information:
Interest	832	366
Income taxes	338	340
Non-cash investing activities:
Non-cash consideration for business acquisition		133
Non-cash financing activities:
Vesting of restricted stock units		$ 117

Note 1 - Basis of Presentation

Note 1 - Basis of Presentation	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. Basis of Presentation The accompanying consolidated interim financial statements of RCM Technologies, Inc. and subsidiaries (“RCM” or the “Company”) are unaudited. The year-end consolidated balance sheet was derived from audited statements but does not 10 December 30, 2017 10 The consolidated financial statements for the unaudited interim periods presented include all adjustments (consisting only of normal, recurring adjustments) necessary for a fair presentation of financial position, results of operations and cash flows for such interim periods. Results for the thirteen thirty-nine September 29, 2018 not may Fiscal Year The Company follows a 52/53 December 31. December 30, 2017 52 third 2018 2017 Period Ended Weeks in Quarter Weeks in Year to Date September 29, 2018 Thirteen Thirty-Nine September 30, 2017 Thirteen Thirty-Nine

Note 2 - Use of Estimates and U

Note 2 - Use of Estimates and Uncertainties	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	2. Use of Estimates and Uncertainties The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and disclosure of contingent assets and liabilities. Actual results could differ from those estimates. The Company uses estimates to calculate an allowance for doubtful accounts on its accounts receivables, adequacy of reserves, goodwill impairment, if any, equity compensation, the tax rate applied and the valuation of certain assets and liability accounts. These estimates can be significant to the operating results and financial position of the Company. The Company has risk participation arrangements with respect to workers compensation and health care insurance. The amounts included in the Company’s costs related to this risk participation are estimated and can vary based on changes in assumptions, the Company’s claims experience or the providers included in the associated insurance programs. The Company can be affected by a variety of factors including uncertainty relating to the performance of the general economy, competition, demand for the Company’s services, adverse litigation and claims and the hiring, training and retention of key employees. F air Value of Financial Instruments The Company’s carrying value of financial instruments, consisting primarily of accounts receivable, transit accounts receivable, accounts payable and accrued expenses, and transit accounts payable and borrowings under line of credit approximates fair value due to their liquidity or their short-term nature. The Company does not

Note 3 - Revenue Recognition

Note 3 - Revenue Recognition	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	3. Revenue Recognition As of December 31, 2017, 2014 09, Revenue from Contracts with Customers ("ASC 606" , 606 not December 31, 2017. We evaluate our revenue contracts with customers based on the five 606: 1 2 3 4 5 The Company derives its revenues from several sources. The Company’s Engineering Services and Information Technology Services segments perform consulting and project solution services. All of the Company’s segments perform staff augmentation services and derive revenue from permanent placement fees. The majority of the Company’s revenues are invoiced on a time and materials basis. The following table presents our revenues disaggregated by revenue source for the thirty-nine September 29, 2018 September 30, 2017: September 29, 2018 September 30, 2017 Engineering: Time and Material $ 56,639 $ 52,843 Fixed Fee 5,773 8,674 Total Engineering $ 62,412 $ 61,517 Specialty Health Care: Time and Material $ 59,457 $ 47,554 Permanent Placement Services 1,142 1,658 Total Specialty Health Care $ 60,599 $ 49,212 Information Technology: Time and Material $ 21,875 $ 24,671 Permanent Placement Services 195 280 Total Information Technology $ 22,070 $ 24,951 $ 145,081 $ 135,680 Time and Material The Company’s IT and Healthcare segments predominantly recognize revenue through time and material work while its Engineering segment recognizes revenue through both time and material and fixed fee work. The Company’s time and material contracts are typically based on the number of hours worked at contractually agreed upon rates, therefore revenues associated with these time and materials contracts are recognized based on hours worked at contracted rates. Fixed fee From time to time and predominantly in our Engineering segment, the Company will enter into contracts requiring the completion of specific deliverables. The Company has master services agreements with many of its customers that broadly define terms and conditions. Actual services performed under fixed fee arrangements are typically delivered under purchase orders that more specifically define terms and conditions related to that fixed fee project. While these master services agreements can often span several years, the Company’s fixed fee purchase orders are typically performed over six nine not not Permanent Placement Services The Company earns permanent placement fees from providing permanent placement services. These fees are typically based on a percentage of the compensation paid to the person placed with the Company’s client. There was no September 29, 2018. December 30, 2017 $596 may one thirty-nine September 29, 2018, $596

Note 4 - Accounts Receivable, T

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	4. Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable The Company’s accounts receivable are comprised as follows: September 29, 2018 December 30, 2017 Billed $ 30,106 $ 31,448 Accrued and unbilled 12,131 10,573 Work-in-progress 5,704 5,026 Allowance for sales discounts and doubtful accounts (1,278 ) (967 ) Accounts receivable, net $ 46,663 $ 46,080 Unbilled receivables primarily represent revenues earned whereby those services are ready to be billed as of the balance sheet ending date. Work-in-progress primarily represents revenues earned under contracts which the Company contractually invoices at future dates. From time to time, the Company’s Engineering segment enters into agreements to provide, among other things, construction management and engineering services. Pursuant to these agreements, the Company a) may no not not $4.4 $4.5 $0.1 September 29, 2018. $3.0 $4.7 $1.7 December 30, 2017. The Company has a dispute with a customer that is a major utility in the United States. Essentially, the customer has not September 29, 2018 $6.2 September 29, 2018, $11.5 not no first 2019. no not one not

Note 5 - Property and Equipment

Note 5 - Property and Equipment	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	5. Property and Equipment Property and equipment are stated at cost and are depreciated on the straight-line method at rates calculated to provide for retirement of assets at the end of their estimated useful lives. The annual rates are 20% Property and equipment are comprised of the following: September 29, 2018 December 30, 2017 Computers and systems $ 7,133 $ 6,172 Equipment and furniture 600 938 Leasehold improvements 693 899 8,426 8,009 Less: accumulated depreciation and amortization 4,732 4,563 Property and equipment, net $ 3,694 $ 3,446 The Company periodically writes off fully depreciated and amortized assets. The Company wrote off fully depreciated and amortized assets of $994 $367 thirty-nine September 29, 2018 September 30, 2017, thirty-nine September 29, 2018 September 30, 2017 $1,116 $1,179,

Note 6 - Acquisitions

Note 6 - Acquisitions	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Business Combination Disclosure [Text Block]	6. Acquisitions The Company has acquired numerous companies throughout its history and those acquisitions have generally included significant future contingent consideration. The Company gives no no The Company made the following acquisitions during fiscal 2017: RAF April 16, 2017, 1991 $133, 1 $123; 2 $10 2017. PSR Effective October 1, 2017 2006 3D 30 three $3,248 $1,000, $1,763 $485 $237. $58 Future Contingent Payments As of September 29, 2018, three may 1 July 1, 2012 2 July 5, 2015, 3 October 1, 2017, September 29, 2018 Fiscal Years Ending Total December 29, 2018 (after September 29, 2018) $ 553 December 28, 2019 450 January 2, 2021 730 Estimated future contingent consideration payments $ 1,733 Estimates of future contingent payments are subject to significant judgment and actual payments may $2.4 September 29, 2018. not 820 10 35 3 no thirty-nine September 29, 2018. The Company paid contingent consideration of $0.3 $0.8 thirty-nine September 29, 2018 September 30, 2017,

Note 7 - Goodwill

Note 7 - Goodwill	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Goodwill Disclosure [Text Block]	7. Goodwill Goodwill represents the premium paid over the fair value of the net tangible and intangible assets acquired in business combinations. The Company tests goodwill for impairment on an annual basis as of the last day of the Company's fiscal year or more frequently if events occur or circumstances change indicating that the fair value of goodwill may no thirty-nine September 29, 2018. There were no thirty-nine September 29, 2018. Engineering Specialty Health Care Information Technology Total Balance as of September 29, 2018 and December 30, 2017 $ 7,249 $ 2,398 $ 2,038 $ 11,685

Note 8 - Intangible Assets

Note 8 - Intangible Assets	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	8. Intangible Assets The Company evaluates long-lived assets and intangible assets with definite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not not no Intangible assets are substantially attributable to the Company’s Engineering segment and include the following: Thirty-Nine Week Periods Ended September 29, 2018 December 30, 2017 Customer contracts and relations $ 56 $ 88 Non-compete agreements 9 17 Intangible assets, net $ 65 $ 105 Amortization expense of intangible assets for the thirty-nine September 29, 2018 September 30, 2017 $40 $50,

Note 9 - Line of Credit

Note 9 - Line of Credit	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Debt Disclosure [Text Block]	9. Line of Credit The Company and its subsidiaries amended and restated its Revolving Credit Facility with Citizens Bank of Pennsylvania on August 9, 2018. $45.0 $40.0 no $5.0 August 8, 2023. $1.4 December 31, 2018 Borrowings under the Revolving Credit Facility bear interest at one two 30 not thirty-nine September 29, 2018 3.8%. All borrowings under the Revolving Credit Facility are collateralized by all of the assets of the Company and its subsidiaries and a pledge of the stock of its subsidiaries. The Revolving Credit Facility also contains various financial and non-financial covenants, such as a covenant that restricts on the Company’s ability to borrow in order to pay dividends. As of September 29, 2018, Borrowings under the line of credit as of September 29, 2018 December 30, 2017 $24.5 $27.3 September 29, 2018 December 30, 2017 $0.8 September 29, 2018, $19.7

Note 10 - Per Share Data

Note 10 - Per Share Data	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Earnings Per Share [Text Block]	1 0 . Per Share Data The Company uses the treasury stock method to calculate the weighted-average shares used for diluted earnings per share. The number of common shares used to calculate basic and diluted earnings per share for the thirteen thirty-nine September 29, 2018 September 30, 2017 Thirteen Week Periods Ended Thirty-Nine Week Periods Ended September 29, 2018 September 30, 2017 September 29, 2018 September 30, 2017 Basic weighted average shares outstanding 12,284,727 12,009,181 12,254,415 11,972,600 Dilutive effect of outstanding restricted stock awards 32,723 141,914 24,165 116,610 Weighted average dilutive shares outstanding 12,317,450 12,151,095 12,278,580 12,089,210 For both the thirteen thirty-nine September 29, 2018, no not no thirteen thirty-nine September 30, 2017 15,000 not Unissued shares of common stock were reserved for the following purposes: September 29, 2018 December 30, 2017 Time-based restricted stock units outstanding 96,195 87,034 Performance-based restricted stock units outstanding 240,000 400,000 Future grants of options or shares 483,071 332,232 Shares reserved for employee stock purchase plan 86,403 177,280 Total 905,669 996,546

Note 11 - Share-based Compensat

Note 11 - Share-based Compensation	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	11. Share-Based Compensation At September 29, 2018, two one three 10 may Share-based compensation expense of $322 $591 thirty-nine September 29, 2018 September 30, 2017, thirty-nine September 29, 2018 not September 29, 2018, As of September 29, 2018, $253 two not may Incentive S hare-Based Plans 2014 2014 The 2014 December 2014, 625,000 2016, 2014 500,000 1,125,000 December 1, 2026. As of September 29, 2018, 2014 96,195 240,000 483,071 Employee Stock Purchase Plan The Company implemented the 2001 January 1, 2001. 85% 10% In fiscal 2015, 300,000 1,100,000 December 31, 2025. The Company has two first two two first July 2, 2018) 45,469. September 29, 2018, 86,403 Time-Based Restricted Stock Units From time-to-time the Company issues time-based restricted stock units. These time-based restricted stock units typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period assuming the grantee’s restricted stock unit fully vests. Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying consolidated balance sheet. Dividends for time-based restricted stock units that ultimately do not To date, the Company has issued time-based restricted stock units only under its 2007 2014 2007 no 2014 thirty-nine September 29, 2018: Number of Time-Based Restricted Stock Units Weighted Average Grant Date Fair Value per Share Outstanding non-vested at December 30, 2017 87,034 $ 5.88 Granted 15,000 $ 5.33 Vested - - Forfeited or expired 5,839 $ 6.85 Outstanding non-vested at September 29, 2018 96,195 $ 5.74 Based on the closing price of the Company’s common stock of $4.27 September 28, 2018 ( September 29, 2018), September 29, 2018 $411. September 29, 2018, $253 Performance Based Restricted Stock Units From time-to-time the Company issues performance-based restricted stock units to its executives. Performance-based restricted stock units are typically vested based on certain multi-year performance metrics as determined by the Board of Directors Compensation Committee. These performance-based restricted stock units typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period on any stock units that actually vest, if any. Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying consolidated balance sheet. Dividends for performance-based restricted stock units that ultimately do not To date, the Company has issued performance-based restricted stock units only under the 2014 2018: Number of Performance-Based Restricted Stock Units Weighted Average Grant Date Fair Value per Share Outstanding non-vested at December 30, 2017 400,000 $ 5.11 Granted 200,000 $ 5.66 Vested - - Forfeited or expired 360,000 $ 5.29 Outstanding non-vested at September 29, 2018 240,000 $ 5.29 As of September 29, 2018, 240,000 no no

Note 12 - Treasury Stock Transa

Note 12 - Treasury Stock Transactions	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Treasury Stock [Text Block]	12. Treasury Stock Transactions For the thirty-nine September 29, 2018, not not thirty-nine September 30, 2017, 59,312 $6.16.

Note 13 - New Accounting Standa

Note 13 - New Accounting Standards and Updates from the Securities Exchange Commission ("SEC")	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]	13. New Accounting Standards and Updates from the Securities Exchange Commission (“SEC”) In February 2016, 2016 02, Leases (Topic 842 , 2016 02 2016 02 December 15, 2018 ( 2016 02 first 2019. may 1 2 second January 1, 2019 not not January 1, 2019. not In June 2016, 2016 13, Financial Instruments - Credit Losses (Topic 326 December 15, 2018, not 2016 13 In August 2018, 10 X, 3 04,2 1 2 3 04 November 5, 2018. not first 10 10 March 31, 2019. not

Note 14 - Segment Information

Note 14 - Segment Information	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	1 4 . Segment Information The Company follows “Disclosures about Segments of an Enterprise and Related Information,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note 1 10 December 30, 2017). Segment operating income includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments. The following tables reflect the results of the reportable segments consistent with the Company’s management system: Thirteen Week Period Ended September 29, 2018 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 19,424 $ 15,106 $ 8,029 $ - $ 42,559 Cost of services 14,049 11,665 5,857 - 31,571 Gross profit 5,375 3,441 2,172 - 10,988 Selling, general and administrative 3,780 3,648 1,984 - 9,412 Depreciation and amortization 236 85 23 - 344 Operating income (loss) $ 1,359 $ (292 ) $ 165 $ - $ 1,232 Total assets as of September 29, 2018 $ 40,643 $ 18,874 $ 7,110 $ 6,801 $ 73,428 Capital expenditures $ 465 $ 151 $ 90 $ 110 $ 816 Thirteen Week Period Ended September 30, 2017 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 21,708 $ 14,335 $ 7,784 $ - $ 43,827 Cost of services 15,533 10,805 5,771 - 32,109 Gross profit 6,175 3,530 2,013 - 11,718 Selling, general and administrative 3,968 3,750 1,982 - 9,700 Depreciation and amortization 297 86 39 - 422 Operating income (loss) $ 1,910 $ (306 ) $ (8 ) $ - $ 1,596 Total assets as of September 30, 2017 $ 33,721 $ 16,178 $ 10,212 $ 3,937 $ 64,048 Capital expenditures $ 138 $ 44 $ - $ 13 $ 195 Thirty-Nine Week Period Ended September 29, 2018 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 62,412 $ 60,599 $ 22,070 $ - $ 145,081 Cost of services 45,706 46,822 16,275 - 108,803 Gross profit 16,706 13,777 5,795 - 36,278 Selling, general and administrative 12,006 12,255 5,648 - 29,909 Depreciation and amortization 785 294 77 - 1,156 Severance, professional fees and other charges - - - 1,371 1,371 Operating income (loss) $ 3,915 $ 1,228 $ 70 $ (1,371 ) $ 3,842 Total assets as of September 29, 2018 $ 40,643 $ 18,874 $ 7,110 $ 6,801 $ 73,428 Capital expenditures $ 856 $ 207 $ 108 $ 243 $ 1,414 Thirty-Nine Week Period Ended September 30, 2017 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 61,517 $ 49,212 $ 24,951 $ - $ 135,680 Cost of services 44,598 37,069 18,430 - 100,097 Gross profit 16,919 12,143 6,521 - 35,583 Selling, general and administrative 12,184 11,429 6,479 - 30,092 Change in contingent consideration - - - 781 781 Depreciation and amortization 863 246 120 - 1,229 Operating income (loss) $ 3,872 $ 468 $ (78 ) $ (781 ) $ 3,481 Total assets as of September 30, 2017 $ 33,721 $ 16,178 $ 10,212 $ 3,937 $ 64,048 Capital expenditures $ 247 $ 459 $ - $ 41 $ 747 The Company derives a majority of its revenue from offices in the United States. Revenues reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Serbia. Revenues by geographic area for the thirty-nine September 29, 2018 September 30, 2017 Thirteen Week Periods Ended Thirty-Nine Week Periods Ended September 29, 2018 September 30, 2017 September 29, 2018 September 30, 2017 Revenues U. S. $ 34,729 $ 34,207 $ 118,364 $ 110,083 Canada 6,308 8,703 21,942 22,420 Puerto Rico 1,113 917 3,142 3,177 Serbia 409 - 1,633 - $ 42,559 $ 43,827 $ 145,081 $ 135,680 Total assets by geographic area as of the reported periods are as follows: September 29, 2018 December 30, 2017 Total assets U. S. $ 50,309 $ 52,595 Canada 17,382 15,419 Puerto Rico 1,823 1,891 Serbia 3,914 3,374 $ 73,428 $ 73,279

Note 15 - Income Taxes

Note 15 - Income Taxes	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Income Tax Disclosure [Text Block]	15. Income Taxes On December 22, 2017, No. 118, 118” not may one December 29, 2018. 118 fifty-two December 30, 2017. 2017 $1.2 $1.0 $0.2 2017 2018 September 29, 2018, 2017 2018 The projected fiscal 2018 September 29, 2018 thirty-nine September 29, 2018 28.1%, 26.5% 15.2% 25.8% thirty-nine September 29, 2018. 42.5% 26.5% 34.7% thirty-nine September 30, 2017. not thirty-nine September 29, 2018 21.0% 34.0% $0.8 37.9%.

Note 16 - Contingencies

Note 16 - Contingencies	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Contingencies Disclosure [Text Block]	16. Contingencies From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business. As such, the Company is required to assess the likelihood of any adverse outcomes to these matters as well as potential ranges of losses and possible recoveries. The Company may not may $11.5 September 29, 2018. September 29, 2018, The Company has a dispute with a customer that is a major utility in the United States. Essentially, the customer has not September 29, 2018 $6.2 September 29, 2018, $11.5 not no first 2019. no not one not The Company is also subject to other pending legal proceedings and claims that arise from time to time in the ordinary course of its business, which may not

Note 17 - Severance, Profession

Note 17 - Severance, Professional Fees and Other Charges	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Severance, Professional Fees and Other Charges Disclosure [Text Block]	17. Severance , Professional Fees and Other Charges The Company recorded $1.4 thirty-nine September 29, 2018. $0.9 $0.5 not

Note 18 - Subsequent Events

Note 18 - Subsequent Events	9 Months Ended
	Sep. 29, 2018
Notes to Financial Statements
Subsequent Events [Text Block]	18. Effective October 1, 2018, $3.7 $1.8 440,751 $7.6 three

Note 3 - Revenue Recognition (T

Note 3 - Revenue Recognition (Tables)	9 Months Ended
	Sep. 29, 2018
Notes Tables
Disaggregation of Revenue [Table Text Block]	September 29, 2018 September 30, 2017 Engineering: Time and Material $ 56,639 $ 52,843 Fixed Fee 5,773 8,674 Total Engineering $ 62,412 $ 61,517 Specialty Health Care: Time and Material $ 59,457 $ 47,554 Permanent Placement Services 1,142 1,658 Total Specialty Health Care $ 60,599 $ 49,212 Information Technology: Time and Material $ 21,875 $ 24,671 Permanent Placement Services 195 280 Total Information Technology $ 22,070 $ 24,951 $ 145,081 $ 135,680

Note 4 - Accounts Receivable,_2

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable (Tables)	9 Months Ended
	Sep. 29, 2018
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	September 29, 2018 December 30, 2017 Billed $ 30,106 $ 31,448 Accrued and unbilled 12,131 10,573 Work-in-progress 5,704 5,026 Allowance for sales discounts and doubtful accounts (1,278 ) (967 ) Accounts receivable, net $ 46,663 $ 46,080

Note 5 - Property and Equipme_2

Note 5 - Property and Equipment (Tables)	9 Months Ended
	Sep. 29, 2018
Notes Tables
Property, Plant and Equipment [Table Text Block]	September 29, 2018 December 30, 2017 Computers and systems $ 7,133 $ 6,172 Equipment and furniture 600 938 Leasehold improvements 693 899 8,426 8,009 Less: accumulated depreciation and amortization 4,732 4,563 Property and equipment, net $ 3,694 $ 3,446

Note 6 - Acquisitions (Tables)

Note 6 - Acquisitions (Tables)	9 Months Ended
	Sep. 29, 2018
Notes Tables
Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]	Fiscal Years Ending Total December 29, 2018 (after September 29, 2018) $ 553 December 28, 2019 450 January 2, 2021 730 Estimated future contingent consideration payments $ 1,733

Note 7 - Goodwill (Tables)

Note 7 - Goodwill (Tables)	9 Months Ended
	Sep. 29, 2018
Notes Tables
Schedule of Goodwill [Table Text Block]	Engineering Specialty Health Care Information Technology Total Balance as of September 29, 2018 and December 30, 2017 $ 7,249 $ 2,398 $ 2,038 $ 11,685

Note 8 - Intangible Assets (Tab

Note 8 - Intangible Assets (Tables)	9 Months Ended
	Sep. 29, 2018
Notes Tables
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	Thirty-Nine Week Periods Ended September 29, 2018 December 30, 2017 Customer contracts and relations $ 56 $ 88 Non-compete agreements 9 17 Intangible assets, net $ 65 $ 105

Note 10 - Per Share Data (Table

Note 10 - Per Share Data (Tables)	9 Months Ended
	Sep. 29, 2018
Notes Tables
Schedule of Weighted Average Number of Shares [Table Text Block]	Thirteen Week Periods Ended Thirty-Nine Week Periods Ended September 29, 2018 September 30, 2017 September 29, 2018 September 30, 2017 Basic weighted average shares outstanding 12,284,727 12,009,181 12,254,415 11,972,600 Dilutive effect of outstanding restricted stock awards 32,723 141,914 24,165 116,610 Weighted average dilutive shares outstanding 12,317,450 12,151,095 12,278,580 12,089,210
Unissued Shares of Common Stock [Table Text Block]	September 29, 2018 December 30, 2017 Time-based restricted stock units outstanding 96,195 87,034 Performance-based restricted stock units outstanding 240,000 400,000 Future grants of options or shares 483,071 332,232 Shares reserved for employee stock purchase plan 86,403 177,280 Total 905,669 996,546

Note 11 - Share-based Compens_2

Note 11 - Share-based Compensation (Tables)	9 Months Ended
	Sep. 29, 2018
Notes Tables
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	Number of Time-Based Restricted Stock Units Weighted Average Grant Date Fair Value per Share Outstanding non-vested at December 30, 2017 87,034 $ 5.88 Granted 15,000 $ 5.33 Vested - - Forfeited or expired 5,839 $ 6.85 Outstanding non-vested at September 29, 2018 96,195 $ 5.74 Number of Performance-Based Restricted Stock Units Weighted Average Grant Date Fair Value per Share Outstanding non-vested at December 30, 2017 400,000 $ 5.11 Granted 200,000 $ 5.66 Vested - - Forfeited or expired 360,000 $ 5.29 Outstanding non-vested at September 29, 2018 240,000 $ 5.29

Note 14 - Segment Information (

Note 14 - Segment Information (Tables)	9 Months Ended
	Sep. 29, 2018
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Thirteen Week Period Ended September 29, 2018 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 19,424 $ 15,106 $ 8,029 $ - $ 42,559 Cost of services 14,049 11,665 5,857 - 31,571 Gross profit 5,375 3,441 2,172 - 10,988 Selling, general and administrative 3,780 3,648 1,984 - 9,412 Depreciation and amortization 236 85 23 - 344 Operating income (loss) $ 1,359 $ (292 ) $ 165 $ - $ 1,232 Total assets as of September 29, 2018 $ 40,643 $ 18,874 $ 7,110 $ 6,801 $ 73,428 Capital expenditures $ 465 $ 151 $ 90 $ 110 $ 816 Thirteen Week Period Ended September 30, 2017 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 21,708 $ 14,335 $ 7,784 $ - $ 43,827 Cost of services 15,533 10,805 5,771 - 32,109 Gross profit 6,175 3,530 2,013 - 11,718 Selling, general and administrative 3,968 3,750 1,982 - 9,700 Depreciation and amortization 297 86 39 - 422 Operating income (loss) $ 1,910 $ (306 ) $ (8 ) $ - $ 1,596 Total assets as of September 30, 2017 $ 33,721 $ 16,178 $ 10,212 $ 3,937 $ 64,048 Capital expenditures $ 138 $ 44 $ - $ 13 $ 195 Thirty-Nine Week Period Ended September 29, 2018 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 62,412 $ 60,599 $ 22,070 $ - $ 145,081 Cost of services 45,706 46,822 16,275 - 108,803 Gross profit 16,706 13,777 5,795 - 36,278 Selling, general and administrative 12,006 12,255 5,648 - 29,909 Depreciation and amortization 785 294 77 - 1,156 Severance, professional fees and other charges - - - 1,371 1,371 Operating income (loss) $ 3,915 $ 1,228 $ 70 $ (1,371 ) $ 3,842 Total assets as of September 29, 2018 $ 40,643 $ 18,874 $ 7,110 $ 6,801 $ 73,428 Capital expenditures $ 856 $ 207 $ 108 $ 243 $ 1,414 Thirty-Nine Week Period Ended September 30, 2017 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 61,517 $ 49,212 $ 24,951 $ - $ 135,680 Cost of services 44,598 37,069 18,430 - 100,097 Gross profit 16,919 12,143 6,521 - 35,583 Selling, general and administrative 12,184 11,429 6,479 - 30,092 Change in contingent consideration - - - 781 781 Depreciation and amortization 863 246 120 - 1,229 Operating income (loss) $ 3,872 $ 468 $ (78 ) $ (781 ) $ 3,481 Total assets as of September 30, 2017 $ 33,721 $ 16,178 $ 10,212 $ 3,937 $ 64,048 Capital expenditures $ 247 $ 459 $ - $ 41 $ 747
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]	Thirteen Week Periods Ended Thirty-Nine Week Periods Ended September 29, 2018 September 30, 2017 September 29, 2018 September 30, 2017 Revenues U. S. $ 34,729 $ 34,207 $ 118,364 $ 110,083 Canada 6,308 8,703 21,942 22,420 Puerto Rico 1,113 917 3,142 3,177 Serbia 409 - 1,633 - $ 42,559 $ 43,827 $ 145,081 $ 135,680
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]	September 29, 2018 December 30, 2017 Total assets U. S. $ 50,309 $ 52,595 Canada 17,382 15,419 Puerto Rico 1,823 1,891 Serbia 3,914 3,374 $ 73,428 $ 73,279

Note 3 - Revenue Recognition (D

Note 3 - Revenue Recognition (Details Textual) - USD ($) $ in Thousands	9 Months Ended
	Sep. 29, 2018	Dec. 30, 2017
Contract with Customer, Liability, Revenue Recognized	$ 596
Accounts Payable and Accrued Liabilities [Member]
Contract with Customer, Liability, Total	$ 0	$ 596

Note 3 - Revenue Recognition -

Note 3 - Revenue Recognition - Revenues Disaggregated by Revenue Source (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Sep. 29, 2018	Sep. 30, 2017
Revenues	$ 42,559	$ 43,827	$ 145,081	$ 135,680
Engineering Services [Member]
Revenues			62,412	61,517
Health Care [Member]
Revenues			60,599	49,212
Technology Service [Member]
Revenues			22,070	24,951
Time-and-materials Contract [Member] | Engineering Services [Member]
Revenues			56,639	52,843
Time-and-materials Contract [Member] | Health Care [Member]
Revenues			59,457	47,554
Time-and-materials Contract [Member] | Technology Service [Member]
Revenues			21,875	24,671
Fixed-price Contract [Member] | Engineering Services [Member]
Revenues			5,773	8,674
Permanent Placement Services [Member] | Health Care [Member]
Revenues			1,142	1,658
Permanent Placement Services [Member] | Technology Service [Member]
Revenues			$ 195	$ 280

Note 4 - Accounts Receivable,_3

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable (Details Textual) - USD ($) $ in Millions	Sep. 29, 2018	Dec. 30, 2017
Liabilities, Net	$ 0.1	$ 1.7
Loss Contingency, Receivable, Ending Balance	6.2
Loss Contingency, Estimate of Possible Loss	11.5
Collectibility of Receivables [Member]
Loss Contingency, Estimate of Possible Loss	11.5
Transit Accounts Payable [Member]
Accounts Payable, Current, Total	4.5	4.7
Transit Accounts Receivable [Member]
Accounts Receivable, Gross, Current	$ 4.4	$ 3

Note 4 - Accounts Receivable,_4

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable - Accounts Receivable (Details) - USD ($) $ in Thousands	Sep. 29, 2018	Dec. 30, 2017
Allowance for sales discounts and doubtful accounts	$ (1,278)	$ (967)
Accounts receivable, net	46,663	46,080
Billed Revenues [Member]
Accounts receivable, current	30,106	31,448
Unbilled Revenues [Member]
Accounts receivable, current	12,131	10,573
Work In Progress [Member]
Accounts receivable, current	$ 5,704	$ 5,026

Note 5 - Property and Equipme_3

Note 5 - Property and Equipment (Details Textual) - USD ($) $ in Thousands	9 Months Ended
	Sep. 29, 2018	Sep. 30, 2017
Annual Depreciation Rate	20.00%
Write Off of Fully Depreciated Property and Equipment	$ 994	$ 367
Depreciation, Total	$ 1,116	$ 1,179

Note 5 - Property and Equipme_4

Note 5 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Sep. 29, 2018	Dec. 30, 2017
Property and equipment	$ 8,426	$ 8,009
Less: accumulated depreciation and amortization	4,732	4,563
Property and equipment, net	3,694	3,446
Computers and Systems [Member]
Property and equipment	7,133	6,172
Equipment and Furniture [Member]
Property and equipment	600	938
Leasehold Improvements [Member]
Property and equipment	$ 693	$ 899

Note 6 - Acquisitions (Details

Note 6 - Acquisitions (Details Textual) - USD ($) $ in Thousands	Oct. 01, 2017	Apr. 16, 2017	Sep. 29, 2018	Sep. 30, 2017	Dec. 30, 2017
Payment for Contingent Consideration Liability, Financing Activities			$ 300	$ 790
Payments to Acquire Businesses, Gross			300	$ 800
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High			$ 2,400
RAF Services, Inc [Member]
Business Combination, Consideration Transferred, Total		$ 133
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities, Total		$ 123
Payment for Contingent Consideration Liability, Financing Activities					$ 10
PSR Engineering Solutions d.o.o. Beograd (Voždovac) [Member]
Business Combination, Consideration Transferred, Total	$ 3,248
Payments to Acquire Businesses, Gross	1,000
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	1,763
Business Combination, Consideration Transferred, Liabilities Incurred	485
Cash Acquired from Acquisition	237
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment, Total	$ 58

Note 6 - Acquisitions - Maximum

Note 6 - Acquisitions - Maximum Deferred Consideration Payments (Details) $ in Thousands	Sep. 29, 2018USD ($)
December 29, 2018 (after September 29, 2018)	$ 553
December 28, 2019	450
January 2, 2021	730
Estimated future contingent consideration payments	$ 1,733

Note 7 - Goodwill (Details Text

Note 7 - Goodwill (Details Textual) $ in Thousands	9 Months Ended
	Sep. 29, 2018USD ($)
Goodwill, Impairment Loss	$ 0
Goodwill, Period Increase (Decrease), Total	$ 0

Note 7 - Goodwill - Changes in

Note 7 - Goodwill - Changes in Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands	Sep. 29, 2018	Dec. 30, 2017
Balance	$ 11,685	$ 11,685
Engineering [Member]
Balance	7,249
Specialty Health Care [Member]
Balance	2,398
Information Technology [Member]
Balance	$ 2,038

Note 8 - Intangible Assets (Det

Note 8 - Intangible Assets (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Sep. 29, 2018	Sep. 30, 2017
Impairment of Intangible Assets (Excluding Goodwill), Total	$ 0	$ 0	$ 0	$ 0
Amortization of Intangible Assets, Total			$ 40	$ 50

Note 8 - Intangible Assets - In

Note 8 - Intangible Assets - Intangible Assets by Class (Details) - USD ($) $ in Thousands	Sep. 29, 2018	Dec. 30, 2017
Intangible assets, net	$ 65	$ 105
Customer-Related Intangible Assets [Member]
Intangible assets, net	56	88
Noncompete Agreements [Member]
Intangible assets, net	$ 9	$ 17

Note 9 - Line of Credit (Detail

Note 9 - Line of Credit (Details Textual) - USD ($) $ in Thousands	Aug. 09, 2018	Sep. 29, 2018	Aug. 08, 2018	Dec. 30, 2017
Long-term Line of Credit, Noncurrent		$ 24,460		$ 27,279
Citizens Bank of Pennsylvania [Member] | Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity		$ 45,000	$ 40,000
Line of Credit, Loan Covenants, Waiver Granted, Amount of Certain Expenses Excluded	$ 1,400
Debt Instrument, Interest Rate, Effective Percentage		3.80%
Long-term Line of Credit, Noncurrent		$ 24,500		27,300
Letters of Credit Outstanding, Amount		800		$ 800
Line of Credit Facility, Remaining Borrowing Capacity		$ 19,700
Citizens Bank of Pennsylvania [Member] | Letter of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity			$ 5,000

Note 10 - Per Share Data (Detai

Note 10 - Per Share Data (Details Textual) - shares	3 Months Ended		9 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Sep. 29, 2018	Sep. 30, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	15,000	0	15,000

Note 10 - Per Share Data - Weig

Note 10 - Per Share Data - Weighted Average Number of Common Shares (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Sep. 29, 2018	Sep. 30, 2017
Basic weighted average shares outstanding (in shares)	12,284,727	12,009,181	12,254,415	11,972,600
Dilutive effect of outstanding restricted stock awards (in shares)	32,723	141,914	24,165	116,610
Weighted average dilutive shares outstanding (in shares)	12,317,450	12,151,095	12,278,580	12,089,210

Note 10 - Per Share Data - Unis

Note 10 - Per Share Data - Unissued Shares of Common Stock Were Reserved for the Following Purposes (Details) - shares	Sep. 29, 2018	Dec. 30, 2017
Future grants of options or shares (in shares)	483,071	332,232
Shares reserved for employee stock purchase plan (in shares)	86,403	177,280
Total (in shares)	905,669	996,546
Time-based Restricted Stock Units [Member]
Restricted stock units outstanding (in shares)	96,195	87,034
Performance-based Restricted Stock Units [Member]
Restricted stock units outstanding (in shares)	240,000	400,000

Note 11 - Share-based Compens_3

Note 11 - Share-based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	Jul. 02, 2018	Sep. 29, 2018	Sep. 30, 2017	Dec. 31, 2016	Jan. 02, 2016	Sep. 28, 2018	Dec. 30, 2017	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		10 years
Allocated Share-based Compensation Expense, Total		$ 322	$ 591
Common Stock, Capital Shares Reserved for Future Issuance		905,669					996,546
Share Price						$ 4.27
The 2014 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		1,125,000						625,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized				500,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant		483,071
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant		86,403
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date		85.00%
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate		10.00%
Additional Shares of Common Stock Reserved for Future Issuance					300,000
Common Stock, Capital Shares Reserved for Future Issuance					1,100,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans	45,469
Performance-based Restricted Stock Units [Member]
Allocated Share-based Compensation Expense, Total		$ 0
Performance-based Restricted Stock Units [Member] | The 2014 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance		240,000					400,000
Time-based Restricted Stock Units [Member]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total		$ 253
Time-based Restricted Stock Units [Member] | The 2014 Plan [Member]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total		$ 253
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition		2 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance		96,195					87,034
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested		$ 411
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		1 year
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		3 years

Note 11 - Share-based Compens_4

Note 11 - Share-based Compensation - Restricted Stock Units Activity (Details) - The 2014 Plan [Member]	9 Months Ended
	Sep. 29, 2018$ / sharesshares
Time-based Restricted Stock Units [Member]
Outstanding non-vested (in shares) | shares	87,034
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 5.88
Granted (in shares) | shares	15,000
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 5.33
Vested (in shares) | shares
Vested, weighted average grant date fair value (in dollars per share) | $ / shares
Forfeited or expired (in shares) | shares	5,839
Forfeited or expired, weighted average grant date fair value (in dollars per share) | $ / shares	$ 6.85
Outstanding non-vested (in shares) | shares	96,195
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 5.74
Performance-based Restricted Stock Units [Member]
Outstanding non-vested (in shares) | shares	400,000
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 5.11
Granted (in shares) | shares	200,000
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 5.66
Vested (in shares) | shares	0
Vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 0
Forfeited or expired (in shares) | shares	360,000
Forfeited or expired, weighted average grant date fair value (in dollars per share) | $ / shares	$ 5.29
Outstanding non-vested (in shares) | shares	240,000
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 5.29

Note 12 - Treasury Stock Tran_2

Note 12 - Treasury Stock Transactions (Details Textual) - Stock Repurchase Program, 2016 [Member] - $ / shares	9 Months Ended
	Sep. 29, 2018	Sep. 30, 2017
Treasury Stock, Shares, Acquired	0	59,312
Treasury Stock Acquired, Average Cost Per Share		$ 6.16

Note 14 - Segment Information -

Note 14 - Segment Information - Results of the Segments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Sep. 29, 2018	Sep. 30, 2017	Dec. 30, 2017
Revenues	$ 42,559	$ 43,827	$ 145,081	$ 135,680
Cost of services	31,571	32,109	108,803	100,097
Gross profit	10,988	11,718	36,278	35,583
Selling, general and administrative	9,412	9,700	29,909	30,092
Depreciation and amortization	344	422	1,156	1,229
Operating income (loss)	1,232	1,596	3,842	3,481
Total assets	73,428	64,048	73,428	64,048	$ 73,279
Capital expenditures	816	195	1,414	747
Severance, professional fees and other charges			1,371	0
Change in contingent consideration				781
Engineering [Member]
Revenues	19,424	21,708	62,412	61,517
Cost of services	14,049	15,533	45,706	44,598
Gross profit	5,375	6,175	16,706	16,919
Selling, general and administrative	3,780	3,968	12,006	12,184
Depreciation and amortization	236	297	785	863
Operating income (loss)	1,359	1,910	3,915	3,872
Total assets	40,643	33,721	40,643	33,721
Capital expenditures	465	138	856	247
Severance, professional fees and other charges
Change in contingent consideration
Specialty Health Care [Member]
Revenues	15,106	14,335	60,599	49,212
Cost of services	11,665	10,805	46,822	37,069
Gross profit	3,441	3,530	13,777	12,143
Selling, general and administrative	3,648	3,750	12,255	11,429
Depreciation and amortization	85	86	294	246
Operating income (loss)	(292)	(306)	1,228	468
Total assets	18,874	16,178	18,874	16,178
Capital expenditures	151	44	207	459
Severance, professional fees and other charges
Change in contingent consideration
Information Technology [Member]
Revenues	8,029	7,784	22,070	24,951
Cost of services	5,857	5,771	16,275	18,430
Gross profit	2,172	2,013	5,795	6,521
Selling, general and administrative	1,984	1,982	5,648	6,479
Depreciation and amortization	23	39	77	120
Operating income (loss)	165	(8)	70	(78)
Total assets	7,110	10,212	7,110	10,212
Capital expenditures	90		108
Severance, professional fees and other charges
Change in contingent consideration
Corporate Segment [Member]
Revenues
Cost of services
Gross profit
Selling, general and administrative
Depreciation and amortization
Operating income (loss)			(1,371)	(781)
Total assets	6,801	3,937	6,801	3,937
Capital expenditures	$ 110	$ 13	243	41
Severance, professional fees and other charges			$ 1,371
Change in contingent consideration				$ 781

Note 14 - Segment Information_2

Note 14 - Segment Information - Revenues by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Sep. 29, 2018	Sep. 30, 2017
Revenues	$ 42,559	$ 43,827	$ 145,081	$ 135,680
UNITED STATES
Revenues	34,729	34,207	118,364	110,083
CANADA
Revenues	6,308	8,703	21,942	22,420
PUERTO RICO
Revenues	1,113	917	3,142	3,177
SERBIA
Revenues	$ 409		$ 1,633

Note 14 - Segment Information_3

Note 14 - Segment Information - Total Assets by Geographic Area (Details) - USD ($) $ in Thousands	Sep. 29, 2018	Dec. 30, 2017	Sep. 30, 2017
Total assets	$ 73,428	$ 73,279	$ 64,048
UNITED STATES
Total assets	50,309	52,595
CANADA
Total assets	17,382	15,419
PUERTO RICO
Total assets	1,823	1,891
SERBIA
Total assets	$ 3,914	$ 3,374

Note 15 - Income Taxes (Details

Note 15 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Sep. 29, 2018	Sep. 30, 2017	Dec. 30, 2017
Tax Adjustments, Settlements, and Unusual Provisions					$ 1,200
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability					1,000
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount					$ 200
Effective Income Tax Rate Reconciliation, Percent, Total			25.80%	34.70%
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability				$ 781
Effective Income Tax Rate Reconciliation, Excluding Discrete Permanent Differences, Percent				37.90%
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Effective Income Tax Rate Reconciliation, Percent, Total			28.10%	42.50%
Foreign Tax Authority [Member] | Canada Revenue Agency [Member]
Effective Income Tax Rate Reconciliation, Percent, Total			26.50%	26.50%
Foreign Tax Authority [Member] | Ministry of Finance, Republic of Serbia [Member]
Effective Income Tax Rate Reconciliation, Percent, Total			15.20%

Note 16 - Contingencies (Detail

Note 16 - Contingencies (Details Textual) $ in Millions	9 Months Ended
	Sep. 29, 2018USD ($)
Loss Contingency, Damages Sought, Value	$ 11.5
Loss Contingency, Receivable, Ending Balance	6.2
Loss Contingency, Estimate of Possible Loss	$ 11.5

Note 17 - Severance, Professi_2

Note 17 - Severance, Professional Fees and Other Charges (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Sep. 29, 2018	Sep. 30, 2017
Severance, Professional Fees and Other Charges			$ 1,371	$ 0
Transactional Advisory Fees, Legal Fees, and Search Fees [Member]
Severance, Professional Fees and Other Charges			500
Former Chief Executive Officer [Member] | Severance Accrued and Related Payroll Taxes, Continuation of Certain Benefits and Professional Fees [Member]
Severance, Professional Fees and Other Charges			$ 900

Note 18 - Subsequent Events (De

Note 18 - Subsequent Events (Details Textual) - USD ($) $ in Thousands	Oct. 01, 2018	Sep. 29, 2018	Sep. 30, 2017
Payments to Acquire Businesses, Gross		$ 300	$ 800
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High		$ 2,400
TKE [Member] | Subsequent Event [Member]
Business Combination, Consideration Transferred, Total	$ 3,700
Payments to Acquire Businesses, Gross	$ 1,800
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	440,751
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	$ 7,600